Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

The World Health Organization has declared an international health emergency due to an Ebola outbreak in the Democratic Republic of Congo. ...

Quote of the Day: Melinda French Gates states that societies move backward when men make decisions for women. Her words champion equality a...

A groundbreaking cooling system called Nescod is here. Developed by scientists, it cools without electricity. This innovation uses common m...

Moderna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Oxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...

Two stories highlight how AI can empower rather than replace humans. In one, a software engineer used tools like ChatGPT and AlphaFold, alo...

A US study suggests a link between infectious mononucleosis and a higher risk of developing multiple sclerosis. The research indicates that...

Zydus Lifesciences is set to develop a combination vaccine against shigellosis and typhoid with the Gates Foundation's support. The vaccine...

Combining vaccines, say with a first dose of a viral vector vaccine like Oxford-AstraZeneca’s Covishield and a second dose of an mRNA jab l...

Scientists have for the first time found that it is possible to generate simultaneous immune response against Hepatitis C virus and HIV, ra...

Hyderabad-based Bharat Biotech International said it has launched Comvac5, a single shot pentavalent combination vaccine for hepatitis.

Panacea Biotec has been pre-qualified by WHO for supplying innovative combination vaccines for pediatric immunization-EasyFour (DTP + Hib) ...

Panacea Biotec Ltd has entered into an agreement with Family Vaccines of Philippines to provide access to value added combination vaccines ...